These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25720556)

  • 1. Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan.
    Ramasamy T; Ruttala HB; Choi JY; Tran TH; Kim JH; Ku SK; Choi HG; Yong CS; Kim JO
    Chem Commun (Camb); 2015 Apr; 51(26):5758-61. PubMed ID: 25720556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
    Reddy JA; Dorton R; Bloomfield A; Nelson M; Vetzel M; Guan J; Leamon CP
    Clin Cancer Res; 2014 Apr; 20(8):2104-14. PubMed ID: 24429878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin.
    Liao L; Liu J; Dreaden EC; Morton SW; Shopsowitz KE; Hammond PT; Johnson JA
    J Am Chem Soc; 2014 Apr; 136(16):5896-9. PubMed ID: 24724706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticle-supported lipid bilayers for drug delivery.
    Mattingly SJ; O'Toole MG; James KT; Clark GJ; Nantz MH
    Langmuir; 2015 Mar; 31(11):3326-32. PubMed ID: 25714501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
    Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft.
    Shaikh IM; Tan KB; Chaudhury A; Liu Y; Tan BJ; Tan BM; Chiu GN
    J Control Release; 2013 Dec; 172(3):852-61. PubMed ID: 24459693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.
    Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM
    Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695
    [No Abstract]   [Full Text] [Related]  

  • 8. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ; Du XJ; Mao CQ; Wang J
    J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
    Han H; Davis ME
    Bioconjug Chem; 2013 Apr; 24(4):669-77. PubMed ID: 23461746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel design of a polynuclear co-delivery system for safe and efficient cancer therapy.
    Xing L; Zhang JL; Zhou TJ; He YJ; Cui PF; Gong JH; Sun M; Lu JJ; Huang Z; Jin L; Jiang HL
    Chem Commun (Camb); 2018 Aug; 54(63):8737-8740. PubMed ID: 30027958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy.
    Zheng M; Yue C; Ma Y; Gong P; Zhao P; Zheng C; Sheng Z; Zhang P; Wang Z; Cai L
    ACS Nano; 2013 Mar; 7(3):2056-67. PubMed ID: 23413798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
    Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
    Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
    Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
    Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
    Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
    Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles.
    Wang Y; Ma S; Xie Z; Zhang H
    Colloids Surf B Biointerfaces; 2014 Apr; 116():41-8. PubMed ID: 24441457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight polymer-drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinations.
    Camacho KM; Menegatti S; Mitragotri S
    Nanomedicine (Lond); 2016 May; 11(9):1139-51. PubMed ID: 27079141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
    Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
    J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.